| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/28/2005 | US20050165055 Novel substituted indoles |
| 07/28/2005 | US20050165053 Substituted4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/28/2005 | US20050165052 combining substituted quinolines with a carrier; leishmania/HIV infection; viricide, parasiticide |
| 07/28/2005 | US20050165051 Taxanes having a C7 carbonate substituent |
| 07/28/2005 | US20050165050 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 07/28/2005 | US20050165048 For prophylaxis and therapy of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders |
| 07/28/2005 | US20050165047 alpha 7 nicotinic acetylcholine receptor agonist; dissolving N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide to an alcohol, adding fumaric acid, precipitating salt out of the solution; neurodegenerative and psychological disorders |
| 07/28/2005 | US20050165046 Bis-bicyclic amides and derivatives thereof and compositions containing them for the treatment of acute, inflammatory and neuropathic pain; 4-chloro-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-(trifluoromethyl)-3-quinolinecarboxamide |
| 07/28/2005 | US20050165045 Compounds and methods |
| 07/28/2005 | US20050165044 Use against Trypanosoma brucei rhodesiense (T.b.r.) and Plasmodium falciparum; prodrugs of these compounds can be used as oral treatment for malaria and human African trypanosomiasis; 2,7-bis-guanidino-9H-fluorene, 2,7-bis-guanidinofluoren-9-one |
| 07/28/2005 | US20050165043 Immune response modifier imiquimod; certain immune response modifier (IRM) compounds can be used to improve skin quality, and in preventing, reversing, or reducing the formation of a scar |
| 07/28/2005 | US20050165042 Fused tricyclic heterocycles useful for treating hyper-proliferative disoroders |
| 07/28/2005 | US20050165041 Combination for the treatment of airway disorders |
| 07/28/2005 | US20050165039 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 07/28/2005 | US20050165036 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 07/28/2005 | US20050165034 Novel heterocyclic derivatives of tripeptides and tripeptide mimetics; (+-)-2-[3-[(benzylsulfonyl)amino]-6-methyl-2-oxo-1 (2H)-pyridinyl]-N-[(4,5,6,7-tetrahydro-2H-indazole-5-yl]acetamide; anticoagulants |
| 07/28/2005 | US20050165033 mediated by prostaglandin D2, a ligand for orphan receptor CRTH2; rhinitis; N-substituted by a benzothiazolyl, a pyrimidinyl, an imidazolyl, an oxazolyl, or a thiazolyl |
| 07/28/2005 | US20050165032 Vanilloid receptor ligands and their use in treatments |
| 07/28/2005 | US20050165031 1-(4-(3-(Pyridin-4-yl)propoxy)phenyl)-3-(5-tert-butylisoxazol-3-yl)urea; inhibits protein tyrosine kinases or a specific kinase or kinase class; for for treating and preventing conditions and diseases such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis |
| 07/28/2005 | US20050165030 Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
| 07/28/2005 | US20050165029 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases |
| 07/28/2005 | US20050165028 e.g. 4-bromo-N-(2,3-dihydro-1,4-benzodioxin-6-yl)benzamide; analgesics, neuropathic pain, inflammation, arthritis, rheumatic diseases, inflammatory bowel disorders, eye disorders, or bladder disorders, psoriasis, wounds, burns, allergic skin, herpes simplex |
| 07/28/2005 | US20050165025 neuromuscular dysfunction of the lower urinary tract; incontinence, overactive bladder, cystitis; serotonin (5-HT) |
| 07/28/2005 | US20050165024 Urea derivatives as kinase modulators |
| 07/28/2005 | US20050165023 Imidazo-triazine derivatives as ligands for gaba receptors |
| 07/28/2005 | US20050165022 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/28/2005 | US20050165021 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
| 07/28/2005 | US20050165019 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 07/28/2005 | US20050165018 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 07/28/2005 | US20050165017 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165015 Vanilloid receptor ligands and their use in treatments |
| 07/28/2005 | US20050165014 1 4-dihydro-1 4-diphenylpyridine derivatives |
| 07/28/2005 | US20050165013 used for inflammatory or respiratory system disorders such as asthma or chronic obstructive pulmonary disease |
| 07/28/2005 | US20050165011 6-[5-(6-methyl-pyridin-2-yl)-1H-[1,2,3]triazol-4-yl]-4H-benzo[1,4]oxazin-3-one, used as inhibitors of the transforming growth factor beta-signalling pathways, in particular, the phosphorylation of smad gene and proteins or activin-like kinase receptors; prophylaxis of kidney fibrosis |
| 07/28/2005 | US20050165010 administering pyrazino(2,3-d)pyrimidine derivatives, for therapy of respiratory system disorders such as asthma or chronic obstructive pulmonary disease |
| 07/28/2005 | US20050165009 Remedy for glioblastoma |
| 07/28/2005 | US20050165008 7-chloro-4-(2-fluoroethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide; AMPA (alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid)modulators; antidepressant, anxiolytic agent |
| 07/28/2005 | US20050165007 Benzimidazoles and analogs thereof as antivirals |
| 07/28/2005 | US20050165006 Quinoline derivatives, their preparation and pharmaceutical compositions comprising the same |
| 07/28/2005 | US20050165005 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them |
| 07/28/2005 | US20050165003 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
| 07/28/2005 | US20050165001 Quinazolinone and benzoxazinone derivatives and uses thereof |
| 07/28/2005 | US20050164998 Of pregnant mares; filtering solids, basic buffering, reducing phenolic content, separating esterified steroids using a series of nonionic and ionic exchange resins; improved industrial scale batch uniformity of conjugated estrogens over Premarin"; hormone replacement therapy |
| 07/28/2005 | US20050164997 a 3-oxo-androstancarbothioic acid compound; respiaratory system disorder |
| 07/28/2005 | US20050164996 a 3-oxo-androstane carbothioic acid compound; mixture with disodium edatate preservative |
| 07/28/2005 | US20050164995 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 07/28/2005 | US20050164993 Methods of treating allergic reactions |
| 07/28/2005 | US20050164992 Treating inflammatory bowel disease by administering prostaglandin derivatives such as (3-{(1R,4S,5S)-5-(3-chloro-benzo[b]thiophen-2-yl)-3-hydroxy-pent-1-enyl]-4-hydroxy-3,3-dimethyl-2-oxo-cyclopentylsulfanyl}-propylsulfanyl)-acetic acid methyl ester |
| 07/28/2005 | US20050164990 Piperidinyl prostaglandin e analogs |
| 07/28/2005 | US20050164989 Novel $g(a)-amino-n-(diaminophosphinyl) lactam derivative |
| 07/28/2005 | US20050164988 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia |
| 07/28/2005 | US20050164987 Melatonin combination therapy for improving sleep quality |
| 07/28/2005 | US20050164986 Especially the sulfobutyl ether cyclodextrin, Captisol"; simplified aqueous formulations without conventional preservatives; nontoxic; storage stability and freeze resistance; biostatic and biocidal towards E coli, Pseudomonas aeruginzosa, Stapphylococcus aureus, Candida albicans, and Aspergillus niger |
| 07/28/2005 | US20050164985 Therapeutic application of enoxaparin |
| 07/28/2005 | US20050164983 Carboxyl-reduced derivatives of dermatan sulfate, preparation thereof, use thereof as a medicinal product and the pharmaceutical compositions containing them |
| 07/28/2005 | US20050164982 Glycomimetics linked to a benzyl amino sulfonic acid (BASA) and combined with another diagnostic or therapeutic agent; inhibition of tissue transplant rejection and cell adhesion |
| 07/28/2005 | US20050164981 Injection of a synthetic synovial fluid containing one or more phosphatides, such as dipalmitoyl phosphatidylcholine, and a biodegradable dextran-glycidyl methacrylate copolymer hydrogel; phosphatides are incorporated into the cartilage of the arthritic, injured, or diseased joint; antiarthritic agents |
| 07/28/2005 | US20050164980 Endcapped block polymers including ethylene oxide-propylene oxide, glycolic acid-lactic acid, or ethylene oxide-lactic or glycolic acid; low viscosity allows easy injection; capable of room temperature distribution; extended analgesic effectiveness; nontoxic antiarthritic agents; tissue repair |
| 07/28/2005 | US20050164979 Pharmaceutical composition for ophthalmological and rhinological application |
| 07/28/2005 | US20050164978 An oral, controlled release dosage form of a hexokinase inhibitor, chosen from mannoheptulose or glucoheptulose, and a gamma-aminobutyric acid activity enhancer, such as glutamic acid, and baclofen; insulin resistance; weight control |
| 07/28/2005 | US20050164977 A contraceptive or hormone replacement therapy kit with at least 10 oral dosage units; preventing fetal damage, peripheral neuropathy, paresthesia or ataxia caused by vitamin B12 deficiency |
| 07/28/2005 | US20050164976 Combination of a cdk inhibitor and 5-fu for the tratment of cancer |
| 07/28/2005 | US20050164975 Purine receptor inhibition as a therapeutic strategy in spinal cord and brain |
| 07/28/2005 | US20050164973 E.g., 3-[5-(4-Fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid; treating diseases ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay |
| 07/28/2005 | US20050164972 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/28/2005 | US20050164971 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 07/28/2005 | US20050164964 Mixture of a nucleic acid and a chitosan with branching groups attached to the amino group, selected from alkyl groups with 2 or more carbon atoms, monosaccharides, oligosaccharides or polysaccharides; gene therapy, genetic vaccines, antisense therapy, anticarcinogenic agents, autoimmune diseases |
| 07/28/2005 | US20050164960 Administering substituted (beta -D-ribofuranosyl)purines or (beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidines alone or incombination with cidofovir, ribavirin, levovirin, or viramidine, particularly against vaccinia virus or variola virus infections |
| 07/28/2005 | US20050164959 Method of treating eye infections with azithromycin |
| 07/28/2005 | US20050164958 O-alkyl macrolide and azalide derivatives and regioselective process for their preparation |
| 07/28/2005 | US20050164957 7-Hydroxy chromones as potent antioxidants |
| 07/28/2005 | US20050164956 Nitrogen oxide (NO) responsive health conditions, hypertension, cardiovascular disorders, coronary artery disease and/or vascular disorders, heart attacks, strokes, congestive heart failure and/or kidney failure; dimers, trimers, or oligomers connected via interflavan linkages |
| 07/28/2005 | US20050164955 Biosynthesis by fermentation of Candida to form a mixture of lactonic and non-lactonic sophorolipids; separating, utilizing as fungicide; alkyl 17-L-[(2'-O- beta -D-glucopyranosyl- beta -D-glucopyranosyl)-oxy]-cis-9-octadecenoate derivatives |
| 07/28/2005 | US20050164954 formula (I) has an inhibitory activity against cysteine protease and therefore it is useful as an agent for the prophylaxis and/or treatment of inflammatory diseases, diseases induced by apoptosis, diseases induced by disorders of immune responses, autoimmune diseases, diseases induced by decomposition |
| 07/28/2005 | US20050164951 Inhibitors for the soluble epoxide hydrolase |
| 07/28/2005 | US20050164948 Methods of treatment with prosaposin-derived peptides |
| 07/28/2005 | US20050164933 Method of reducing injury to mammalian cells |
| 07/28/2005 | US20050164921 7-Methoxy-2,4-disubstituted quinoline derivatives |
| 07/28/2005 | US20050164913 Mixture of ionic surfactant, chelate compound and solvent preferable water; bactericide against grampositive, gramnegative bacteria |
| 07/28/2005 | US20050164911 Unifying mechanism and methods to prevent cancer and neurodegenerative diseases |
| 07/28/2005 | US20050164909 Methods and reagents for treating inflammation and fibrosis |
| 07/28/2005 | US20050164908 Neuroprotective complex for treatment of cerebral ischemia and injury |
| 07/28/2005 | US20050164395 Synthetic urine and method of manufacturing same |
| 07/28/2005 | US20050164391 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/28/2005 | US20050164313 Methods and compositions for the detection of cervical cancer |
| 07/28/2005 | US20050164305 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 07/28/2005 | US20050164298 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor(ghs) |
| 07/28/2005 | US20050164278 Breast cancer specific genes (BSG) and diagnosing/preventing cell proliferative disorders; immunotherapy; paramagnetic imaging |
| 07/28/2005 | US20050164267 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics |
| 07/28/2005 | US20050164263 identification of amino acid sequences and proteins related to MAP/ERK subfamily; gene chip; transgenic nonhuman animal; nucleic acid vector; expression in larynx epithelium, Wilms' tumors of the kidney, pancreas adenocarcinomas, fetal brain, and hippocampus; models for human therapeutic targets |
| 07/28/2005 | US20050164235 Modified iRNA agents |
| 07/28/2005 | US20050164212 Modulation of gene expression using DNA-RNA hybrids |
| 07/28/2005 | US20050164194 Growth regulating proteins |
| 07/28/2005 | US20050163879 Composition for preventing or treating dementia comprising a hydroxycinnamic acid derivative or an extract of a plant of genus Angelicae containing same |
| 07/28/2005 | US20050163878 Therapeutic agent of skin diseases |
| 07/28/2005 | US20050163877 Novel hepatic disorder suppressant |
| 07/28/2005 | US20050163875 Novel hepatic disorder suppressant |
| 07/28/2005 | US20050163873 Methods and formulations for treating glaucoma |
| 07/28/2005 | US20050163872 mixtures of plant extracts, glucans or beta-sitosterol containing sterols, used as anticholesterol agents in foods and beverages |